Forodesine


Published: June 11, 2009
Abstract Views: 138
PDF: 112
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Forodesine is a potent, selective, transition state inhibitor (i) of the enzyme purine nucleoside phosphorylase (PNP). It’s mechanisms of action is distinct from other purine nucleoside analogues in that forodesine does not act through interaction with nucleic acid. Selective PNPi leads to intracellular accumulation of dGTP in target lymphocytes and subsequent apoptosis. In vitro, Tcell lymphocytes are sensitive to forodesine. Based on these observations, a series of studies in subjects with cutaneous T-cell lymphoma were performed with single agent forodesine.

Supporting Agencies


Olsen, E. (2009). Forodesine. Hematology Meeting Reports (formerly Haematologica Reports), 3(1). https://doi.org/10.4081/hmr.v3i1.541

Downloads

Citations